Other languages Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
5.65 ^CNY	-0.70%		-3.91%	-50.35%

13/06	Kehua Bio-Engineering's Growth Factor Kit Gets Registration Certificate	MT
28/04	Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kehua Bio-Engineering's Growth Factor Kit Gets Registration Certificate	13/06
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections	21/03
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit	05/03
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.	29/02
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit	19/02
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.	29/23/29
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.	27/23/27
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	16/23/16
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit	14/23/14
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments	30/23/30
Kehua Bio-Engineering Registers Diagnostic Reagent	22/23/22
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023	29/23/29
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21/23/21
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for 2022	19/23/19
Kehua Bio-Engineering Registers Tumor Necrosis Testing Kit	06/23/06
Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Final Cash Dividend for the Year 2022	24/23/24
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

Other languages

Filters